Bodenstedt Matthias 4
4 · MoonLake Immunotherapeutics · Filed Jan 9, 2026
Insider Transaction Report
Form 4
Bodenstedt Matthias
Chief Financial Officer
Transactions
- Award
Class A ordinary shares, par value $0.0001 per share
2026-01-07+354,296→ 1,276,305 total
Footnotes (1)
- [F1]Represents shares of restricted stock that vest in four equal annual installments on January 7, 2027, 2028, 2029 and 2030, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date.